Catharine L. Anderson

Array ( [id] => 16397319 [patent_doc_number] => 20200338177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-29 [patent_title] => CHIMERIC ANTIGEN RECEPTORS THAT BIND TO SSEA4 AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/931676 [patent_app_country] => US [patent_app_date] => 2020-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3227 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16931676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17548176 [patent_doc_number] => 20220119517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-21 [patent_title] => ANTI-CLAUDIN18.2 ANTIBODY AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/271033 [patent_app_country] => US [patent_app_date] => 2019-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18143 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17271033 [rel_patent_id] =>[rel_patent_doc_number] =>)